Loading…

Suicide

Element Considered Final Measures in Toolkit

Suicidal Ideation

  • Wish to Die
  • Passive Thoughts
  • Active Thoughts
  • Intent
  • Plan
  • Lifetime
  • Recent
  • Frequency
  • Duration
 Classification of Suicidal Ideation and Suicidal Behavior
Intensity of Suicide Ideation (Continuum)
Suicidal Intent of Suicide Attempts

Suicidal Behavior

  • Attempts
  • Interrupted by Self or Others
  • Preparatory Behavior
  • Lifetime
  • Recent
 Classification of Suicidal Ideation and Suicidal Behavior (cross-listed in Suicidal Ideation)

Lethality

  • Method
  • Severity
 Lethality of Suicide Attempts

Risk and Protective Factors

  • Non-suicidal Self-Injury Behavior
  • Impulsivity
  • Aggression
  • Hopelessness
  • Depression
  • Addiction
  • Psychosis
  • Insomnia
  • Unemployment
  • Physical Illness
  • Family Conflict
  • Fa
 Non-suicidal Self Injury
Hopelessness
Aggression
Insomnia
Deterrents to Suicide
Access to Lethal Means

Post-traumatic Stress Psychopathology (including PTSD)

Element Considered Final Measures in Toolkit

Trauma Exposure

  • Characteristics (severity, frequency, duration)
  • Age when exposed to trauma (first, most recent, worst)
  • Type of event (descriptive category; also interpersonal vs non-interpersonal)
  • Context (military/civilian)
  • Dimensions of exposure
Trauma Adversity and Exposure

Clinical Characterization (including major comorbidities)

  • Diagnostic and Severity (i.e., categorical and continuous)
  • Screening
  • Non-diagnostic symptom measures
 PTSD Screener
PTSD Symptoms, Self-report
PTSD Symptoms, Severity, and Diagnosis

Moderating and/or Mediating Factors influencing posttraumatic adjustment

  • Adversity in Childhood
  • Education
  • Social Support
  • Mental Health (history)
  • Physical Health (history and current)
  • Life stressors and environment characteristics
 Social Support
Biomarkers (relating clinical characteristics to neurobiology; potential moderators / mediators) Baseline and Trauma Challenge Physiology
Attentional Bias
Resting State fMRI
Functioning and Disability and Treatment-related Factors (refractoriness/responsiveness) General Well-Being
Disability due to Mental Health Symptoms

Eating Disorders

Element Considered Final Measures in Toolkit
Body Mass Index (Weight/Adiposity Status)
Cognitive Functional Domains
  • Emotional Awareness
  • Intolerance of Uncertainty
  • Punishment/Harm Avoidance
  • Sensory/Sensitivity
Eating Disorders Behaviors
  • Childhood Eating Behavior
  • Eating and Weight Patterns
  • Exercise Dependence
  • Obsessive Compulsive Disorder Eating Related Traits
Eating Disorders Diagnosis Eating Disorder Diagnostic
Eating Disorders Psychopathology Psychopathology of Eating Disorders
Physical Comorbidities
Psychiatric Comorbidities Perfectionism

Early Psychosis Clinical Services

Element Considered Final Measures in Toolkit
Family History of Mental Illness Family History of Mental Illness
Adverse Life Events
Premorbid Functioning Premorbid Adjustment in Psychosis
Medical History
Psychiatric Treatment History (including medication history, previous psychosocial interventions, inpatient treatment episodes, emergency department visits and antipsychotic medications at time of enrollments)
Prodromal Psychosis Symptoms
Age of First Prodromal Symptoms
Age of First Psychotic-Level Symptoms
Duration of Untreated Psychosis
Positive Syndrome Symptoms Clinician-Administered Psychiatric Assessment
Global Psychopathology Rating Scale
Current Physical Health (including medication side effects, smoking and cardio-metabolic risk factors) Physical Activity
Antipsychotic Medication Adherence
Antipsychotic Medication Extrapyramidal Side Effects
Multi-dimensional Assessment of Antipsychotic Medication Side Effects
Social and Role Functioning Social and Role Dysfunction in Psychosis and Schizophrenia
Arrests or Incarceration Incarceration
Family Burden Family Burden of Mental Illness
Family Expressed Emotion Toward Relatives with Psychosis and Schizophrenia
Family Functioning
Outpatient Treatments Mental Health Services Satisfaction
Hospitalizations for Psychiatric and Medical Illness (number, duration)
Emergency Department Visits, Crisis Intervention Services
Well-being/Mental Health Recovery Personal Well Being
Quality of Life
Hiring, Training and retention of Coordinated Specialty Care (CSC) staff
Availability of Required CSC Treatment Components
Fidelity Measures Related to Team-based CSC Treatment Model
Quality Measures Related to Provision of CSC Services
Outcome Measures Related to Symptoms, Functioning and Physical Health
CSC Clinic Caseload Size
Measures Related to Initial Engagement (e.g., Client, Family Member, Participation)
Measures Related to Participant Retention/Drop out
Measures of Client and Family Member Satisfaction Mental Health Services Satisfaction
Perception of Recovery Orientation and Care Quality of Mental Health Services
Psychosis Recovery Assessment
Shared Decision Making in Clinical Encounters
Neurocognitive Assessments Auditory Vigilance
Relational Encoding and Retrieval
Context Processing
Global Cognitive Functioning
Electrophysiological Assessments (e.g., ERP)
Eye-Tracking (pre- and Anti-saccade tasks)
Biomarkers and Behavioral Indicators that Predict to Trajectory of Illness C-Reactive Protein in Serum
Functional Brain Imaging Measures Brain Connectivity and Activation
Structural Brain Imaging Measures Brain Anatomical Imaging
Risk and Protective Factors that Span Modalities and Levels of Analysis (e.g., genetic, Brain, Neurobiological, Environmental and Behavioral) and Predict Movement along the illness Trajectory. (Source NIMH Strategic Plan)
Family History of Mental Illness Family History of Mental Illness
Adverse life Events
Premorbid Functioning Premorbid Adjustment in Psychosis
Medical History
Psychiatric Treatment History (including medication history, previous psychosocial interventions, inpatient treatment episodes, emergency department visits and antipsychotic medications at time of enrollments)
Prodromal Psychosis Symptoms
Age of First Prodromal Symptoms
Age of First Psychotic-Level Symptoms
Duration of Untreated Psychosis
Positive Syndrome Symptoms Clinician-Administered Psychiatric Assessment
Global Psychopathology Rating Scale
Current Physical Health (including medication side effects, smoking and cardio-metabolic risk factors) Physical Activity
Antipsychotic Medication Adherence
Antipsychotic Medication Extrapyramidal Side Effects
Multi-dimensional Assessment of Antipsychotic Medication Side Effects
Social and Role Functioning Social and Role Dysfunction in Psychosis and Schizophrenia
Arrests or Incarceration Incarceration
Family Burden Family Burden of Mental Illness
Family Expressed Emotion Toward Relatives with Psychosis and Schizophrenia
Family Functioning
Outpatient Treatments Mental Health Services Satisfaction
Hospitalizations for Psychiatric and Medical Illness (number, duration)
Emergency Department Visits, Crisis Intervention Services
Well-being/Mental Health Recovery Personal Well Being
Quality of Life
Hiring, Training and retention of Coordinated Specialty Care (CSC) staff
Availability of Required CSC Treatment Components
Fidelity Measures Related to Team-based CSC Treatment Model
Quality Measures Related to Provision of CSC Services
Outcome Measures Related to Symptoms, Functioning and Physical Health
CSC Clinic Caseload Size
Measures Related to Initial Engagement (e.g., Client, Family Member, Participation)
Measures Related to Participant Retention/Drop out
Measures of Client and Family Member Satisfaction Mental Health Services Satisfaction
Perception of Recovery Orientation and Care Quality of Mental Health Services
Psychosis Recovery Assessment
Shared Decision Making in Clinical Encounters
Neurocognitive Assessments Auditory Vigilance
Relational Encoding and Retrieval
Context Processing
Global Cognitive Functioning
Electrophysiological Assessments (e.g., ERP)
Eye-Tracking (pre- and Anti-saccade tasks)
Biomarkers and Behavioral Indicators that Predict to Trajectory of Illness C-Reactive Protein in Serum
Functional Brain Imaging Measures Brain Connectivity and Activation
Structural Brain Imaging Measures Brain Anatomical Imaging
Risk and Protective Factors that Span Modalities and Levels of Analysis (e.g., genetic, Brain, Neurobiological, Environmental and Behavioral) and Predict Movement along the illness Trajectory. (Source NIMH Strategic Plan)

Early Psychosis Translational Research

Element Considered Final Measures in Toolkit
Family History of Mental Illness Family History of Mental Illness
Adverse Life Events
Premorbid Functioning Premorbid Adjustment in Psychosis
Medical History
Psychiatric Treatment History (including medication history, previous psychosocial interventions, inpatient treatment episodes, emergency department visits and antipsychotic medications at time of enrollments)
Prodromal Psychosis Symptoms
Age of First Prodromal Symptoms
Age of First Psychotic-Level Symptoms
Duration of Untreated Psychosis
Positive Syndrome Symptoms Clinician-Administered Psychiatric Assessment
Global Psychopathology Rating Scale
Current Physical Health (including medication side effects, smoking and cardio-metabolic risk factors) Physical Activity
Antipsychotic Medication Adherence
Antipsychotic Medication Extrapyramidal Side Effects
Multi-dimensional Assessment of Antipsychotic Medication Side Effects
Social and Role Functioning Social and Role Dysfunction in Psychosis and Schizophrenia
Arrests or Incarceration Incarceration
Family Burden Family Burden of Mental Illness
Family Expressed Emotion Toward Relatives with Psychosis and Schizophrenia
Family Functioning
Outpatient Treatments Mental Health Services Satisfaction
Hospitalizations for Psychiatric and Medical Illness (number, duration)
Emergency Department Visits, Crisis Intervention Services
Well-being/Mental Health Recovery Personal Well Being
Quality of Life
Hiring, Training and retention of Coordinated Specialty Care (CSC) staff
Availability of Required CSC Treatment Components
Fidelity Measures Related to Team-based CSC Treatment Model
Quality Measures Related to Provision of CSC Services
Outcome Measures Related to Symptoms, Functioning and Physical Health
CSC Clinic Caseload Size
Measures Related to Initial Engagement (e.g., Client, Family Member, Participation)
Measures Related to Participant Retention/Drop out
Measures of Client and Family Member Satisfaction Mental Health Services Satisfaction
Perception of Recovery Orientation and Care Quality of Mental Health Services
Psychosis Recovery Assessment
Shared Decision Making in Clinical Encounters
Neurocognitive Assessments Auditory Vigilance
Relational Encoding and Retrieval
Context Processing
Global Cognitive Functioning
Electrophysiological Assessments (e.g., ERP)
Eye-Tracking (pre- and Anti-saccade tasks)
Biomarkers and Behavioral Indicators that Predict to Trajectory of Illness C-Reactive Protein in Serum
Functional Brain Imaging Measures Brain Connectivity and Activation
Structural Brain Imaging Measures Brain Anatomical Imaging
Risk and Protective Factors that Span Modalities and Levels of Analysis (e.g., genetic, Brain, Neurobiological, Environmental and Behavioral) and Predict Movement along the illness Trajectory. (Source NIMH Strategic Plan)
Family History of Mental Illness Family History of Mental Illness
Adverse life Events
Premorbid Functioning Premorbid Adjustment in Psychosis
Medical History
Psychiatric Treatment History (including medication history, previous psychosocial interventions, inpatient treatment episodes, emergency department visits and antipsychotic medications at time of enrollments)
Prodromal Psychosis Symptoms
Age of First Prodromal Symptoms
Age of First Psychotic-Level Symptoms
Duration of Untreated Psychosis
Positive Syndrome Symptoms Clinician-Administered Psychiatric Assessment
Global Psychopathology Rating Scale
Current Physical Health (including medication side effects, smoking and cardio-metabolic risk factors) Physical Activity
Antipsychotic Medication Adherence
Antipsychotic Medication Extrapyramidal Side Effects
Multi-dimensional Assessment of Antipsychotic Medication Side Effects
Social and Role Functioning Social and Role Dysfunction in Psychosis and Schizophrenia
Arrests or Incarceration Incarceration
Family Burden Family Burden of Mental Illness
Family Expressed Emotion Toward Relatives with Psychosis and Schizophrenia
Family Functioning
Outpatient Treatments Mental Health Services Satisfaction
Hospitalizations for Psychiatric and Medical Illness (number, duration)
Emergency Department Visits, Crisis Intervention Services
Well-being/Mental Health Recovery Personal Well Being
Quality of Life
Hiring, Training and retention of Coordinated Specialty Care (CSC) staff
Availability of Required CSC Treatment Components
Fidelity Measures Related to Team-based CSC Treatment Model
Quality Measures Related to Provision of CSC Services
Outcome Measures Related to Symptoms, Functioning and Physical Health
CSC Clinic Caseload Size
Measures Related to Initial Engagement (e.g., Client, Family Member, Participation)
Measures Related to Participant Retention/Drop out
Measures of Client and Family Member Satisfaction Mental Health Services Satisfaction
Perception of Recovery Orientation and Care Quality of Mental Health Services
Psychosis Recovery Assessment
Shared Decision Making in Clinical Encounters
Neurocognitive Assessments Auditory Vigilance
Relational Encoding and Retrieval
Context Processing
Global Cognitive Functioning
Electrophysiological Assessments (e.g., ERP)
Eye-Tracking (pre- and Anti-saccade tasks)
Biomarkers and Behavioral Indicators that Predict to Trajectory of Illness C-Reactive Protein in Serum
Functional Brain Imaging Measures Brain Connectivity and Activation
Structural Brain Imaging Measures Brain Anatomical Imaging
Risk and Protective Factors that Span Modalities and Levels of Analysis (e.g., genetic, Brain, Neurobiological, Environmental and Behavioral) and Predict Movement along the illness Trajectory. (Source NIMH Strategic Plan)